EP2547353
Medical use of a therapeutic combination comprising a thymosin-1-alpha polypeptide and a replication competent retroviral vector for the expression of cytosine deaminase.
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
29.3.2011EP published:
6.3.2019EP application number:
11766479.7
EPO information:
European Patent Register
Max expiry date:
28.3.2031
Title:
Medical use of a therapeutic combination comprising a thymosin-1-alpha polypeptide and a replication competent retroviral vector for the expression of cytosine deaminase.
Timeline
Today
29.3.2011EP application
6.3.2019EP Publication
Owner
Name:
Tocagen Inc.Address:
3030 Bunker Hill Street Suite 230, 92109, San Diego, CA, US
Inventor
Name:
GRUBER, Harry, E.Address:
Rancho Santa Fe, CA, US
Name:
JOLLY, Douglas, J.Address:
Encinitas, CA, US
Name:
PEREZ, OmarAddress:
San Diego, CA, US
Name:
OSTERTAG, Derek, G.Address:
San Diego, CA, US
Name:
ROBBINS, Joan, M.Address:
San Diego, CA, US
Priority
Number:
318728 PDate:
29.3.2010Country:
US
Classification
Categories:
A61K 38/16, A61K 38/17, A61K 38/22, A61K 48/00, C12N 15/86, C12N 15/867, A61P 35/00, C12N 9/78